SCHEMBL4862362

SCHEMBL4862362

CCCN(C)C1CCN(C(=O)c2ccc(I)cc2)C1

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
L3MBTL3 Q96JM7 2/20 0.52
CDK1 P06493 1/20 0.49
CDK2 P24941 1/20 0.49
HRH3 Q9Y5N1 4/20 0.46
L3MBTL1 Q9Y468 1/20 0.44
MGLL Q99685 1/20 0.44
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44
LSS P48449 1/20 0.43
SLC6A2 P23975 1/20 0.42
SLC6A4 P31645 1/20 0.42
SLC6A3 Q01959 1/20 0.42
VNN1 O95497 3/20 0.42
MCHR1 Q99705 1/20 0.42
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1448975 1.00 L3MBTL3 (0.52) L3MBTL3CDK1CDK2HRH3L3MBTL1
SCHEMBL1447551 0.84 L3MBTL3 (0.69) L3MBTL3HRH3L3MBTL1MGLLMCHR1
SCHEMBL1447249 0.84 L3MBTL3 (0.69) L3MBTL3HRH3L3MBTL1MGLLMCHR1
SCHEMBL1447315 0.84 L3MBTL3 (0.69) L3MBTL3HRH3L3MBTL1MGLLMCHR1
SCHEMBL17271879 0.78 L3MBTL3 (0.84) L3MBTL3HRH3L3MBTL1MGLLALDH1A1
SCHEMBL25975209 0.75 L3MBTL3 (0.58) L3MBTL3HRH3L3MBTL1MGLLALDH1A1
SCHEMBL26617906 0.75 ALDH1A1 (0.39) L3MBTL3CDK1CDK2L3MBTL1ALDH1A1
SCHEMBL1449252 0.75 L3MBTL3 (0.49) L3MBTL3HRH3L3MBTL1MGLLLSS
SCHEMBL1449249 0.75 L3MBTL3 (0.49) L3MBTL3HRH3L3MBTL1MGLLLSS
SCHEMBL20624048 0.74 RECQL (0.57) L3MBTL3L3MBTL1MGLLALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912974-A1 IMIDAZOLYL-PYRIMIDINE COMPOUNDS FOR USE IN THE TREATMENT OF PROLIFERATIVE DISORDERS AstraZeneca AB (SE) 2008-04-23 EP disclosed
WO-2007015064-A1 IMIDAZOLYL-PYRIMIDINE COMPOUNDS FOR USE IN THE TREATMENT OF PROLIFERATIVE DISORDERS ASTRAZENECA AB (SE) 2007-02-08 WO disclosed